10-49482809-G-A
Position:
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_000124.4(ERCC6):c.2047C>T(p.Arg683*) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000421 in 1,613,940 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000033 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000043 ( 0 hom. )
Consequence
ERCC6
NM_000124.4 stop_gained
NM_000124.4 stop_gained
Scores
4
2
1
Clinical Significance
Conservation
PhyloP100: 5.69
Genes affected
ERCC6 (HGNC:3438): (ERCC excision repair 6, chromatin remodeling factor) This gene encodes a DNA-binding protein that is important in transcription-coupled excision repair. The encoded protein has ATP-stimulated ATPase activity, interacts with several transcription and excision repair proteins, and may promote complex formation at DNA repair sites. Mutations in this gene are associated with Cockayne syndrome type B and cerebrooculofacioskeletal syndrome 1. Alternative splicing occurs between a splice site from exon 5 of this gene to the 3' splice site upstream of the open reading frame (ORF) of the adjacent gene, piggyback-derived-3 (GeneID:267004), which activates the alternative polyadenylation site downstream of the piggyback-derived-3 ORF. The resulting transcripts encode a fusion protein that shares sequence with the product of each individual gene. [provided by RefSeq, Mar 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 16 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant 10-49482809-G-A is Pathogenic according to our data. Variant chr10-49482809-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 1711.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ERCC6 | NM_000124.4 | c.2047C>T | p.Arg683* | stop_gained | 10/21 | ENST00000355832.10 | NP_000115.1 | |
ERCC6 | NM_001346440.2 | c.2047C>T | p.Arg683* | stop_gained | 10/21 | NP_001333369.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ERCC6 | ENST00000355832.10 | c.2047C>T | p.Arg683* | stop_gained | 10/21 | 1 | NM_000124.4 | ENSP00000348089.5 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152074Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
5
AN:
152074
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251380Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135854
GnomAD3 exomes
AF:
AC:
6
AN:
251380
Hom.:
AF XY:
AC XY:
4
AN XY:
135854
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000431 AC: 63AN: 1461866Hom.: 0 Cov.: 31 AF XY: 0.0000413 AC XY: 30AN XY: 727234
GnomAD4 exome
AF:
AC:
63
AN:
1461866
Hom.:
Cov.:
31
AF XY:
AC XY:
30
AN XY:
727234
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152074Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74272
GnomAD4 genome
AF:
AC:
5
AN:
152074
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
74272
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
0
ExAC
AF:
AC:
4
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Cerebrooculofacioskeletal syndrome 1 Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Nov 20, 2019 | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 01, 2008 | - - |
Cerebrooculofacioskeletal syndrome 1;C0242379:Lung cancer;C0265201:DE SANCTIS-CACCHIONE SYNDROME;C0751038:Cockayne syndrome type 2;C3151063:Age related macular degeneration 5;C3551173:UV-sensitive syndrome 1;C4310783:Premature ovarian failure 11 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 14, 2024 | - - |
ERCC6-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jul 24, 2017 | The ERCC6 c.2047C>T (p.Arg683Ter) variant is a stop-gained variant predicted to result in premature termination of the protein. The p.Arg683Ter variant been reported in two studies in which it is found in two patients including one homozygote with cerebrooculofacioskeletal syndrome (CFSS) and one compound heterozygote with Cockayne syndrome (Laugel et al. 2008; Calmels et al. 2016). Control data are not available for the p.Arg683Ter variant which is reported at a frequency of 0.00005 in the European (non-Finnish) population of the Exome Aggregation Consortium. Western blot analysis demonstrated that the variant resulted in an absence of protein. Complementation assays in CFSS patient fibroblasts transfected with wild type ERCC6 demonstrated rescue of DNA repair deficiency (Laugel et al. 2008). Although the p.Arg683Ter variant is described in the literature in association with autosomal recessive inheritance, an increased risk for macular degeneration due to heterozygous variants may exist. Due to the potential impact of stop-gained variants and evidence from the literature, the p.Arg683Ter variant is classified as likely pathogenic for ERCC6-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 26, 2023 | For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Arg683*) in the ERCC6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ERCC6 are known to be pathogenic (PMID: 18628313, 29572252). This variant is present in population databases (rs121917904, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with Cockayne syndrome (PMID: 18628313, 29572252). ClinVar contains an entry for this variant (Variation ID: 1711). - |
Cockayne syndrome type 1 Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | Royal Medical Services, Bahrain Defence Force Hospital | May 27, 2022 | - - |
DE SANCTIS-CACCHIONE SYNDROME Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | Counsyl | Jan 13, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at